Modified Immunization Vectors
AssigneesArizona Board of Regents, a body corporate of the State of Arizona, acting for and on behalf of Ariz, Consejo Superior De Investgaciones Cientrificas, IPPOX Foundation
InventorsGiuseppe Pantaleo, Thierry Calandra, Alexandre Harari, Thierry Roger, Mario Esteban, Bertram Jacobs, Karen Kibler, Cornelius Melief, Rafick-Pierre Sekaly, Elias Haddad, James Tartaglia
Life of this patent
Estimating the term…
Abstract
The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic.
Claims20
1-34. (canceled)
A recombinant NYVAC vector encoding at least one polypeptide selected from the group consisting of C1L (SEQ ID NO. 5), C2L (SEQ ID NO. 7), C3L (SEQ ID NO. 9), C4L (SEQ ID NO. 11), C5L (SEQ ID NO. 13), C6L (SEQ ID NO. 15), C7L (SEQ ID NO. 17), N1L (SEQ ID NO. 19), N2L (SEQ ID NO. 21), M1L (SEQ ID NO. 23), M2L (SEQ ID NO. 25) and K1L (SEQ ID NO. 27).
A composition comprising a recombinant NYVAC vector of claim 1 and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.